Abstract 6525: Colon cancer screening and treatment with engineered probiotics
Candice R. Gurbatri(Tempus Labs (United States)), Tal Danino(Herbert Irving Comprehensive Cancer Center), Susan L. Woods(South Australian Health and Medical Research Institute), Courtney Coker(Columbia University), Jongwon Im(Columbia University), Daniel L. Worthley(Brisbane Hand & Upper Limb Research Institute), Nicholas Arpaia(Columbia University Irving Medical Center), Georgette Radford(The University of Adelaide)
Cited by 0
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
|Science Translational Medicine|2020|600
Engineering bacteria as interactive cancer therapies
|Science|2022|411